DoubleLine ETF Adviser’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
DoubleLine ETF Adviser's AMGN Position: Q2 2026 in Review
DoubleLine ETF Adviser reduced its Amgen (AMGN) stake by 9.7% in Q2 2026, selling an estimated $223K and leaving 6,079 shares worth $2.2M. The position accounts for 0.91% of the portfolio, ranked #35.
DoubleLine ETF Adviser first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.37M in Q1 2026. 3,145 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- DoubleLine ETF Adviser held 6,079 shares of Amgen worth $2.2M as of Q2 2026.
- DoubleLine ETF Adviser sold 651 Amgen shares in Q2 2026, an estimated $223K.
- Amgen made up 0.91% of DoubleLine ETF Adviser's portfolio in Q2 2026, its #35 holding.
- DoubleLine ETF Adviser first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
- DoubleLine ETF Adviser's Amgen position peaked at $2.37M in Q1 2026.
- 3,145 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.